Allarity Therapeutics enters $6M equity line of credit with Tumim Stone Capital

Allarity Therapeutics, Inc.

Company may sell up to $6M of common stock at 95-97% of VWAP discount.
Commitment fee of $45,000 paid to investor upon execution.
Shares subject to Exchange Cap (19.99% of outstanding) unless stockholder waiver obtained.
Company must seek stockholder approval at next annual meeting to waive Exchange Cap.
Investor cannot own more than 4.99% (or 9.99% at its election) of outstanding shares.

item 1.01item 9.01

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.